Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide.
D000818:Animals; D004285:Dogs; D005934:Glucagon / Q000494:pharmacology; D006003:Glycogen / Q000378:metabolism*; D006943:Hyperglycemia / Q000139:chemically induced*; D066298:In Vitro Techniques; D007421:Intestine, Small / Q000032:analysis*; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D010455:Peptides / Q000302:isolation & purification / Q000494:pharmacology*; D011817:Rabbits; D014665:Vasodilator Agents / Q000302:isolation & purification / Q000494:pharmacology*
D010455:Peptides; D014665:Vasodilator Agents; D006003:Glycogen; D005934:Glucagon